MLYS
Mineralys Therapeutics, Inc. Common StockData: 2026-10-01
Quick Stats
Oct 01, 202650.1
AI Score
HOLD1.28
Volume Ratio
Nov 09, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
MLYS Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
MLYS Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
MLYS Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Daily Out of Money Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Daily In the Money Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Most Active Options by Volume(near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MLYS Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MLYS Stock Summary
Last updated Oct 01, 2026
MLYS is currently trading at $23.72, positioned below its 200-day moving average of $28.49, suggesting bearish momentum. The stock has a 52-week range of $22.3 to $47.65.
Technical Analysis: The 50-day moving average stands at $26.93, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.485, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.08, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MLYS at 50.1/100 with a HOLD recommendation.
MLYS (Mineralys Therapeutics, Inc. Common Stock) Indicators
Last updated Oct 01, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.485 |
| CMF (20) | -0.08 |
| ROC (10) | -15.225 |
| ADX (14) | 16.236 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.677 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -97.76 |
| MFI (14) | 28.171 |
MLYS Candlestick Patterns
No validated candlestick patterns fired for MLYS in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Mineralys Therapeutics, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.
MLYS Moving Averages Analysis
MLYS (Mineralys Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Oct 01, 2026
| Days | MA |
|---|---|
| 10 | 26.4 |
| 20 | 27.65 |
| 30 | 27.13 |
| 50 | 26.93 |
| 100 | 27.03 |
| 200 | 28.49 |
MLYS Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.2 billion |
| Earnings/Share ($) | -4.2 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.4286 |
| EPS Estimate Next Year ($) | -2.5 |
| WallStreet Target Price ($) | 48.50 |
| Most Recent Quarter |
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.